| [1] | SUN L, SHAO Y C, ZHUANG Z H, et al. Targeting TGR5 to mitigate liver fibrosis: Inhibition of hepatic stellate cell activation through modulation of mitochondrial fission[J]. Int Immunopharmacol, 2024, 140: 112831. doi: 10.1016/j.intimp.2024.112831 |
| [2] | WANG N, XU Q H, TAN H Y, et al. Berberine inhibition of fibrogenesis in a rat model of liver fibrosis and in hepatic stellate cells[J]. Evid Based Complement Alternat Med, 2016, 2016: 8762345. doi: 10.1155/2016/8762345 |
| [3] | JIANG Y, WANG C, LI Y Y, et al. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference[J]. J Ethnopharmacol, 2014, 158 Pt A: 230-238. |
| [4] | YANG D M, LI L, QIAN S J, et al. Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway[J]. J Nat Med, 2018, 72(1): 145-154. doi: 10.1007/s11418-017-1122-5 |
| [5] | LIANG Z, ZHANG K Y, GUO H L, et al. Cordycepin alleviates hepatic fibrosis in association with the inhibition of glutaminolysis to promote hepatic stellate cell senescence[J]. Int Immunopharmacol, 2024, 132: 111981. doi: 10.1016/j.intimp.2024.111981 |
| [6] | IGNAT S R, DINESCU S, HERMENEAN A, et al. Cellular interplay as a consequence of inflammatory signals leading to liver fibrosis development[J]. Cells, 2020, 9(2): 461. doi: 10.3390/cells9020461 |
| [7] | XU L, CHEN Y P, NAGASHIMADA M, et al. CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice[J]. Metabolism, 2021, 125: 154914. doi: 10.1016/j.metabol.2021.154914 |
| [8] | 莫思燕, 韦明中, 邱金慧, 等. 基于高迁移率族蛋白B1对老鼠生物碱A抗肝纤维化作用机制的研究[J]. 中国药理学通报, 2016, 32(11): 1553-1558. |
| [9] | 王祖文, 沈以红, 黄先智, 等. 桑叶生物碱对肝纤维化小鼠抗氧化能力及炎症因子水平的影响[J]. 食品科学, 2020, 41(17): 202-207. doi: 10.7506/spkx1002-6630-20190903-023 |
| [10] | ZHAO H W, ZHANG Z F, CHAI X, et al. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways[J]. Int Immunopharmacol, 2016, 36: 249-255. doi: 10.1016/j.intimp.2016.04.040 |
| [11] | LAN T, YU Y, ZHANG J, et al. Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway[J]. Hepatology, 2021, 74(2): 686-703. doi: 10.1002/hep.31749 |
| [12] | HOU X X, LI Y W, SONG J L, et al. Cryptotanshinone induces apoptosis of activated hepatic stellate cells via modulating endoplasmic reticulum stress[J]. World J Gastroenterol, 2023, 29(17): 2616-2627. doi: 10.3748/wjg.v29.i17.2616 |
| [13] | LIU C Y, ZHANG A H. ROS-mediated PERK-eIF2α-ATF4 pathway plays an important role in arsenite-induced L-02 cells apoptosis via regulating CHOP-DR5 signaling[J]. Environ Toxicol, 2020, 35(10): 1100-1113. |
| [14] | DOMITROVIĆ R, JAKOVAC H, MARCHESI V V, et al. Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl4-intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP-2 expression[J]. J Med Food, 2013, 16(6): 518-528. doi: 10.1089/jmf.2012.0175 |
| [15] | ZHANG Z G, LI B, MENG X J, et al. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress[J]. Sci Rep, 2016, 6: 20848. doi: 10.1038/srep20848 |
| [16] | CHEN J Y, YANG Y J, MENG X Y, et al. Oxysophoridine inhibits oxidative stress and inflammation in hepatic fibrosis via regulating Nrf2 and NF-κB pathways[J]. Phytomedicine, 2024, 132: 155585. doi: 10.1016/j.phymed.2024.155585 |
| [17] | HO C, WOO J, HO L, et al. Rutaecarpine protects against acetaminophen-induced acute liver injury in mice by activating antioxidant enzymes[J]. Antioxidants, 2021, 10(1): 86. doi: 10.3390/antiox10010086 |
| [18] | 杜丽娟, 徐军全, 宋彬妤, 等. 川芎嗪对CCl4诱导的肝纤维化大鼠肝组织Nrf2/ARE信号通路的影响[J]. 中国实用医药, 2014, 9(9): 7-8. |
| [19] | BINGÜL İ, AYDıN A F, BAŞARAN-KÜÇÜKGERGIN C, et al. High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats[J]. Int Immunopharmacol, 2016, 39: 199-207. doi: 10.1016/j.intimp.2016.07.028 |
| [20] | XIE Z Y, WU Y H, LIU S F, et al. LncRNA-SNHG7/miR-29b/DNMT3A axis affects activation, autophagy and proliferation of hepatic stellate cells in liver fibrosis[J]. Clin Res Hepatol Gastroenterol, 2021, 45(2): 101469. doi: 10.1016/j.clinre.2020.05.017 |
| [21] | 马子华, 张景允, 杨柳, 等. 氧化苦参碱干预砷致肝星状细胞活化中细胞自噬的研究[J]. 中国病理生理杂志, 2019, 35(9): 1662-1667. |
| [22] | 崔东涛, 马永超, 徐松涛, 等. 氧化槐定碱体内体外通过AKT/mTOR通路调控自噬抑制HBV诱发肝纤维化[J]. 世界科学技术-中医药现代化, 2022, 24(2): 723-731. |
| [23] | TAN Y H, LI C, ZHOU J L, et al. Berberine attenuates liver fibrosis by autophagy inhibition triggering apoptosis via the miR-30a-5p/ATG5 axis[J]. Exp Cell Res, 2023, 427(2): 113600. doi: 10.1016/j.yexcr.2023.113600 |
| [24] | MIYAMAE Y, NISHITO Y, NAKAI N, et al. Tetrandrine induces lipid accumulation through blockade of autophagy in a hepatic stellate cell line[J]. Biochem Biophys Res Commun, 2016, 477(1): 40-46. doi: 10.1016/j.bbrc.2016.06.018 |
| [25] | YANG Y, WANG Y, GUO L, et al. Interaction between macrophages and ferroptosis[J]. Cell Death Dis, 2022, 13(4): 355. doi: 10.1038/s41419-022-04775-z |
| [26] | WANG M, LIU C Y, WANG T, et al. (+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis[J]. Cell Death Dis, 2020, 11(9): 781. doi: 10.1038/s41419-020-02961-5 |
| [27] | YI J Z, WU S Y, TAN S W, et al. Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis[J]. Cell Death Discov, 2021, 7(1): 374. doi: 10.1038/s41420-021-00768-7 |
| [28] | TRIPATHI A, DEBELIUS J, BRENNER D A, et al. The gut-liver axis and the intersection with the microbiome[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(7): 397-411. |
| [29] | QIN J H, LUO Z, WANG Q Y, et al. Integrating metabonomics and metagenomics sequencing to study the anti-liver fibrosis effects of palmatine in Corydalis saxicola Bunting[J]. J Ethnopharmacol, 2023, 315: 116666. doi: 10.1016/j.jep.2023.116666 |